Tata India Pharma & HealthCare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Tata India Pharma & HealthCare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹5000

AUM (Fund size)

₹1,511 Cr

Lock In Period

N/A

Expense Ratio

2.37

Exit Load

0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.

Benchmark

BSE Healthcare Total Return

Tata India Pharma & HealthCare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-8.88-1.39-5.81
6M2.970.9615.51
1Y-2.032.6316.66
3Y15.0613.51108.62

Portfolio Analysis

  • Equity: 99.72%
  • Debt: 0.28%
  • Others
As on: 2026-09-30
View allocation % by

1. SUN PHARMACEUTICAL INDUSTRIES LTD7.99%
2. ABBOTT INDIA LTD5.94%
3. DIVI LABORATORIES LTD5.68%
4. DR REDDYS LABORATORIES LTD4.65%
5. CIPLA LTD4.22%
6. TORRENT PHARMACEUTICALS LTD3.76%
7. LUPIN LTD3.14%
8. SYNGENE INTERNATIONAL LTD2.85%
9. PROCTER & GAMBLE HEALTH LTD2.75%
10. SAI LIFE SCIENCES LTD2.60%
11. ANTHEM BIOSCIENCES LTD2.57%
12. PFIZER LTD2.50%
13. ALKEM LABORATORIES LTD2.36%
14. FDC LTD2.24%
15. ACUTAAS CHEMICALS LTD1.95%
16. AJANTA PHARMA LTD1.63%
17. NATCO PHARMA LTD1.51%
18. IPCA LABORATORIES LTD0.91%
19. SYMBIOTEC PHARMALAB LTD0.87%
20. MANKIND PHARMA LTD0.77%
21. GLAXOSMITHKLINE PHARMACEUTICALS LTD0.76%
22. BIOCON LTD0.69%
23. ZIM LABORATORIES LTD0.58%
24. JUBILANT PHARMOVA LTD0.00%

1. HEALTHCARE GLOBAL ENTERPRISES LTD5.92%
2. APOLLO HOSPITALS ENTERPRISE LTD4.36%
3. RAINBOW CHILDRENS MEDICARE LTD4.30%
4. MAX HEALTHCARE INSTITUTE LTD3.71%
5. FORTIS HEALTHCARE LTD1.95%
6. DR. LAL PATH LABS LTD1.76%
7. ASTER DM QUALITY CARE LTD1.67%
8. DR. AGARWALS HEALTH CARE LTD0.68%
9. MANIPAL HEALTH ENTERPRISES LTD0.59%
10. MOLBIO DIAGNOSTICS LTD0.54%

1. BAYER CROPSCIENCE LTD2.96%
2. PI INDUSTRIES LTD2.59%
3. SUMITOMO CHEMICAL INDIA LTD1.38%

1. GILLETTE INDIA LTD1.23%

1. NAVIN FLUORINE INTERNATIONAL LTD1.18%

1. SANOFI CONSUMER HEALTHCARE INDIA LTD0.57%
2. GUJARAT FLUOROCHEMICALS LTD0.53%
No Data Found
No Data Found

About Fund Tata India Pharma & HealthCare Fund Growth

Tata India Pharma & HealthCare Fund Growth managed by Tata Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,511 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.37. Under the expert guidance of Rajat Srivastava ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Rajat Srivastava

Mr. Rajat Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad. Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services.

Peer Comparison

Tata India Pharma & HealthCare Fund Growth FAQs

Tata India Pharma & HealthCare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Tata India Pharma & HealthCare Fund Growth is 2.37. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Tata India Pharma & HealthCare Fund Growth’s fund performance is as follows:
  • 1 Month : -8.88%
  • 6 Months : 2.97%
  • 1 Year : -2.03%
  • 3 Years : 15.06%
Returns of Tata India Pharma & HealthCare Fund Growth are updated daily based on NAV of ₹ 30.1860 as on Oct 23,2026. Since inception, the return has been 52.32%.

You can invest in Tata India Pharma & HealthCare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Tata India Pharma & HealthCare Fund Growth is ₹1,511 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Tata India Pharma & HealthCare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
  • Daily Research Calls
  • ₹0 AMC for First Year
  • Dedicated RM Support
Open a Free Demat Account
+ Free 1st Year AMC